Can Increased Utilization Of Active Surveillance Rescue The Survival Benefits Of PSA Screening?

UroToday.com - In the lay press and in Washington, prostate cancer has emerged as a litmus test for our health care conundrum of overtreatment and soaring costs in the setting of limited evidence regarding benefit.